238 related articles for article (PubMed ID: 30952930)
1. Radiomic features and multilayer perceptron network classifier: a robust MRI classification strategy for distinguishing glioblastoma from primary central nervous system lymphoma.
Yun J; Park JE; Lee H; Ham S; Kim N; Kim HS
Sci Rep; 2019 Apr; 9(1):5746. PubMed ID: 30952930
[TBL] [Abstract][Full Text] [Related]
2. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning-based Texture Analysis of Contrast-enhanced MR Imaging to Differentiate between Glioblastoma and Primary Central Nervous System Lymphoma.
Kunimatsu A; Kunimatsu N; Yasaka K; Akai H; Kamiya K; Watadani T; Mori H; Abe O
Magn Reson Med Sci; 2019 Jan; 18(1):44-52. PubMed ID: 29769456
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma and primary central nervous system lymphoma: differentiation using MRI derived first-order texture analysis - a machine learning study.
Priya S; Ward C; Locke T; Soni N; Maheshwarappa RP; Monga V; Agarwal A; Bathla G
Neuroradiol J; 2021 Aug; 34(4):320-328. PubMed ID: 33657924
[TBL] [Abstract][Full Text] [Related]
5. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
[TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
7. Application of MR morphologic, diffusion tensor, and perfusion imaging in the classification of brain tumors using machine learning scheme.
Shrot S; Salhov M; Dvorski N; Konen E; Averbuch A; Hoffmann C
Neuroradiology; 2019 Jul; 61(7):757-765. PubMed ID: 30949746
[TBL] [Abstract][Full Text] [Related]
8. Robust performance of deep learning for distinguishing glioblastoma from single brain metastasis using radiomic features: model development and validation.
Bae S; An C; Ahn SS; Kim H; Han K; Kim SW; Park JE; Kim HS; Lee SK
Sci Rep; 2020 Jul; 10(1):12110. PubMed ID: 32694637
[TBL] [Abstract][Full Text] [Related]
9. Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks.
McAvoy M; Prieto PC; Kaczmarzyk JR; Fernández IS; McNulty J; Smith T; Yu KH; Gormley WB; Arnaout O
Sci Rep; 2021 Jul; 11(1):15219. PubMed ID: 34312463
[TBL] [Abstract][Full Text] [Related]
10. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques.
Bathla G; Priya S; Liu Y; Ward C; Le NH; Soni N; Maheshwarappa RP; Monga V; Zhang H; Sonka M
Eur Radiol; 2021 Nov; 31(11):8703-8713. PubMed ID: 33890149
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T
Sun YZ; Yan LF; Han Y; Nan HY; Xiao G; Tian Q; Pu WH; Li ZY; Wei XC; Wang W; Cui GB
BMC Med Imaging; 2021 Feb; 21(1):17. PubMed ID: 33535988
[TBL] [Abstract][Full Text] [Related]
12. Machine learning-based radiomic evaluation of treatment response prediction in glioblastoma.
Patel M; Zhan J; Natarajan K; Flintham R; Davies N; Sanghera P; Grist J; Duddalwar V; Peet A; Sawlani V
Clin Radiol; 2021 Aug; 76(8):628.e17-628.e27. PubMed ID: 33941364
[TBL] [Abstract][Full Text] [Related]
13. Deep Learning for Automatic Differential Diagnosis of Primary Central Nervous System Lymphoma and Glioblastoma: Multi-Parametric Magnetic Resonance Imaging Based Convolutional Neural Network Model.
Xia W; Hu B; Li H; Shi W; Tang Y; Yu Y; Geng C; Wu Q; Yang L; Yu Z; Geng D; Li Y
J Magn Reson Imaging; 2021 Sep; 54(3):880-887. PubMed ID: 33694250
[TBL] [Abstract][Full Text] [Related]
14. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
16. Fully automated radiomics-based machine learning models for multiclass classification of single brain tumors: Glioblastoma, lymphoma, and metastasis.
Joo B; Ahn SS; An C; Han K; Choi D; Kim H; Park JE; Kim HS; Lee SK
J Neuroradiol; 2023 Jun; 50(4):388-395. PubMed ID: 36370829
[TBL] [Abstract][Full Text] [Related]
17. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
18. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
20. Radiomics prognostication model in glioblastoma using diffusion- and perfusion-weighted MRI.
Park JE; Kim HS; Jo Y; Yoo RE; Choi SH; Nam SJ; Kim JH
Sci Rep; 2020 Mar; 10(1):4250. PubMed ID: 32144360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
